The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
Error code: DatasetGenerationCastError
Exception: DatasetGenerationCastError
Message: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 25 new columns ({'event_soc', 'event_pt', 'concomitant_medications', 'bun_mg_dl', 'bilirubin_mg_dl', 'ast_u_l', 'receive_date', 'creatinine_mg_dl', 'action_taken', 'event_hlgt', 'event_duration_days', 'route', 'treatment_duration_days', 'event_hlt', 'weight_kg', 'dose_frequency', 'indication', 'suspect_drug', 'causality_assessment', 'time_to_onset_days', 'event_llt', 'report_type', 'reporter_type', 'seriousness', 'alt_u_l'}) and 25 missing columns ({'dose_freq', 'event_duration', 'reporter_qualification', 'drug_indication', 'drug_name', 'alt', 'serious', 'pt', 'weight', 'route_of_admin', 'causality', 'creatinine', 'ast', 'concomitant_drugs', 'therapy_duration', 'soc', 'action_drug', 'bilirubin', 'fda_dt', 'report_source', 'llt', 'bun', 'ttp_days', 'hlgt', 'hlt'}).
This happened while the csv dataset builder was generating data using
hf://datasets/PrashantRGore/synthetic-faers-1m-v2/synthetic_faers_1m_v2.csv (at revision b57df3af2c006f15ca7ba8ee68746c2ba356bf22)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)
Traceback: Traceback (most recent call last):
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1831, in _prepare_split_single
writer.write_table(table)
File "/usr/local/lib/python3.12/site-packages/datasets/arrow_writer.py", line 714, in write_table
pa_table = table_cast(pa_table, self._schema)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2272, in table_cast
return cast_table_to_schema(table, schema)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2218, in cast_table_to_schema
raise CastError(
datasets.table.CastError: Couldn't cast
case_id: string
receive_date: string
country: string
age: int64
age_group: string
sex: string
weight_kg: double
suspect_drug: string
indication: string
route: string
dose: int64
dose_unit: string
dose_frequency: string
treatment_duration_days: double
event_llt: string
event_pt: string
event_hlt: string
event_hlgt: string
event_soc: string
time_to_onset_days: int64
event_duration_days: double
seriousness: string
outcome: string
action_taken: string
dechallenge: string
rechallenge: string
concomitant_medications: string
medical_history: string
reporter_type: string
report_type: string
causality_assessment: string
alt_u_l: double
ast_u_l: double
bilirubin_mg_dl: double
creatinine_mg_dl: double
bun_mg_dl: double
-- schema metadata --
pandas: '{"index_columns": [{"kind": "range", "name": null, "start": 0, "' + 4656
to
{'case_id': Value('string'), 'fda_dt': Value('string'), 'country': Value('string'), 'age': Value('int64'), 'age_group': Value('string'), 'sex': Value('string'), 'weight': Value('float64'), 'drug_name': Value('string'), 'drug_indication': Value('string'), 'route_of_admin': Value('string'), 'dose': Value('int64'), 'dose_unit': Value('string'), 'dose_freq': Value('string'), 'therapy_duration': Value('float64'), 'llt': Value('string'), 'pt': Value('string'), 'hlt': Value('string'), 'hlgt': Value('string'), 'soc': Value('string'), 'ttp_days': Value('int64'), 'event_duration': Value('float64'), 'serious': Value('string'), 'outcome': Value('string'), 'action_drug': Value('string'), 'dechallenge': Value('string'), 'rechallenge': Value('string'), 'concomitant_drugs': Value('string'), 'medical_history': Value('string'), 'reporter_qualification': Value('string'), 'report_source': Value('string'), 'causality': Value('string'), 'alt': Value('float64'), 'ast': Value('float64'), 'bilirubin': Value('float64'), 'creatinine': Value('float64'), 'bun': Value('float64')}
because column names don't match
During handling of the above exception, another exception occurred:
Traceback (most recent call last):
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1339, in compute_config_parquet_and_info_response
parquet_operations = convert_to_parquet(builder)
^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 972, in convert_to_parquet
builder.download_and_prepare(
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 894, in download_and_prepare
self._download_and_prepare(
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 970, in _download_and_prepare
self._prepare_split(split_generator, **prepare_split_kwargs)
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1702, in _prepare_split
for job_id, done, content in self._prepare_split_single(
^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1833, in _prepare_split_single
raise DatasetGenerationCastError.from_cast_error(
datasets.exceptions.DatasetGenerationCastError: An error occurred while generating the dataset
All the data files must have the same columns, but at some point there are 25 new columns ({'event_soc', 'event_pt', 'concomitant_medications', 'bun_mg_dl', 'bilirubin_mg_dl', 'ast_u_l', 'receive_date', 'creatinine_mg_dl', 'action_taken', 'event_hlgt', 'event_duration_days', 'route', 'treatment_duration_days', 'event_hlt', 'weight_kg', 'dose_frequency', 'indication', 'suspect_drug', 'causality_assessment', 'time_to_onset_days', 'event_llt', 'report_type', 'reporter_type', 'seriousness', 'alt_u_l'}) and 25 missing columns ({'dose_freq', 'event_duration', 'reporter_qualification', 'drug_indication', 'drug_name', 'alt', 'serious', 'pt', 'weight', 'route_of_admin', 'causality', 'creatinine', 'ast', 'concomitant_drugs', 'therapy_duration', 'soc', 'action_drug', 'bilirubin', 'fda_dt', 'report_source', 'llt', 'bun', 'ttp_days', 'hlgt', 'hlt'}).
This happened while the csv dataset builder was generating data using
hf://datasets/PrashantRGore/synthetic-faers-1m-v2/synthetic_faers_1m_v2.csv (at revision b57df3af2c006f15ca7ba8ee68746c2ba356bf22)
Please either edit the data files to have matching columns, or separate them into different configurations (see docs at https://hf.co/docs/hub/datasets-manual-configuration#multiple-configurations)Need help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
case_id
string | fda_dt
string | country
string | age
int64 | age_group
string | sex
string | weight
float64 | drug_name
string | drug_indication
string | route_of_admin
string | dose
int64 | dose_unit
string | dose_freq
string | therapy_duration
float64 | llt
string | pt
string | hlt
string | hlgt
string | soc
string | ttp_days
int64 | event_duration
float64 | serious
string | outcome
string | action_drug
string | dechallenge
string | rechallenge
string | concomitant_drugs
string | medical_history
string | reporter_qualification
string | report_source
string | causality
string | alt
float64 | ast
float64 | bilirubin
float64 | creatinine
float64 | bun
float64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
E787C9A1FC17D940
|
2023-04-19
|
CHN
| 52
|
adult
|
Unknown
| null |
Hematocare
|
Hypothyroidism
|
Subcutaneous
| 5
|
mg
|
Four times daily
| 688
|
High blood pressure
|
Deep vein thrombosis
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 29
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Aspirin
| null |
Physician
|
Spontaneous
|
Probable/Likely
| 12
| 12
| 0.4
| 1
| 16
|
A29236736650CAB3
|
2021-10-30
|
POL
| 45
|
adult
|
Male
| 110.5
|
Osteostrong
|
Bipolar disorder
|
Intravenous
| 50
|
mg
|
Four times daily
| 348
|
AKI
|
Acute kidney injury
|
Acute renal failures
|
Renal failures and impairments
|
Renal and urinary disorders
| 7
| 69
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Hydrochlorothiazide
| null |
Consumer
|
Clinical trial
|
Probable/Likely
| 15
| null | 0.5
| 7.1
| 46
|
837A1C25D1B0ED72
|
2021-09-12
|
ITA
| 92
|
elderly
|
Female
| null |
Hematocare
|
COPD
|
Subcutaneous
| 1
|
mg
|
As needed
| 556
|
Hepatic injury
|
Hepatotoxicity
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 45
| null |
Non-serious
|
Recovering/Resolving
|
Not applicable
|
Not applicable
|
Not applicable
| null |
Hyperlipidemia; Alcohol use disorder; Chronic kidney disease; Previous myocardial infarction
|
Physician
|
Spontaneous
|
Possible
| 340
| null | 9.5
| 0.9
| 15
|
BF1523DD99667C0D
|
2021-10-03
|
USA
| 47
|
adult
|
Male
| 115
|
Vasodilate
|
Schizophrenia
|
Ophthalmic
| 1
|
mg
|
Once daily
| null |
Erythema multiforme
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 5
| 45
|
Non-serious
|
Recovered with sequelae
|
Dose reduced
|
Not applicable
|
Not applicable
| null |
Peripheral vascular disease; Hypothyroidism; Previous myocardial infarction
|
Consumer
|
Spontaneous
|
Possible
| 45
| null | 1.1
| 1.2
| 9
|
F470F722F96A2FF7
|
2021-03-08
|
GBR
| 19
|
adult
|
Female
| 94.4
|
Cardiomax
|
Rheumatoid arthritis
|
Intramuscular
| 5
|
mg
|
Twice daily
| 453
|
Hyperthyroidism
|
Diabetes mellitus
|
Hyperglycaemic conditions NEC
|
Glucose metabolism disorders
|
Endocrine disorders
| 174
| null |
Other medically important condition
|
Recovered with sequelae
|
Dose increased
|
Not applicable
|
Not applicable
|
Pantoprazole; Hydrochlorothiazide
| null |
Pharmacist
|
Spontaneous
|
Unlikely
| 33
| 35
| 0.1
| 1.1
| 12
|
785B2438894CDCFA
|
2025-08-05
|
ESP
| 89
|
elderly
|
Male
| 111.7
|
Eyeprotect
|
Rheumatoid arthritis
|
Topical
| 2
|
mg
|
Three times daily
| null |
AKI
|
Acute kidney injury
|
Acute renal failures
|
Renal failures and impairments
|
Renal and urinary disorders
| 2
| 61
|
Disability
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Warfarin; Aspirin
|
Osteoarthritis; Depression
|
Other health professional
|
Literature
|
Possible
| 27
| 26
| 1.2
| null | null |
5A0796C50364BAA5
|
2023-04-29
|
CAN
| 58
|
adult
|
Unknown
| 58.1
|
Immunoshield
|
Type 2 diabetes
|
Topical
| 1
|
mg
|
As needed
| null |
Blood clot in leg
|
Hypertension
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 14
| 9
|
Non-serious
|
Recovered with sequelae
|
Dose not changed
|
Not applicable
|
Not applicable
|
Atorvastatin; Ciprofloxacin
|
Chronic pain; Hypothyroidism; Heart failure
|
Lawyer
|
Spontaneous
|
Possible
| 28
| 16
| 1.1
| 1.2
| 11
|
BEA3CC1D4F66B39B
|
2022-04-26
|
NLD
| 47
|
adult
|
Unknown
| null |
Eyeprotect
|
Anxiety
|
Intravenous
| 250
|
mg
|
As needed
| 680
|
New malignancy
|
Carcinoma
|
Leukaemias NEC
|
Malignant neoplasms
|
Neoplasms benign, malignant and unspecified
| 54
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Lisinopril
|
Hepatitis B
|
Consumer
|
Spontaneous
|
Possible
| 34
| null | 0.9
| 1.2
| 19
|
A3B710F35B3DBE9E
|
2022-04-13
|
BEL
| 78
|
elderly
|
Unknown
| null |
Thyroregul
|
Schizophrenia
|
Inhalation
| 10
|
mg
|
As needed
| 517
|
Blood clot in lung
|
Pulmonary embolism
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 171
| null |
Non-serious
|
Not recovered/Not resolved
|
Dose reduced
|
Not applicable
|
Not applicable
|
Warfarin
|
Gastroesophageal reflux disease; Occupational radiation exposure; Chronic pain
|
Lawyer
|
Spontaneous
|
Unlikely
| 27
| 32
| 0.4
| null | 10
|
73BDA39A3B797270
|
2021-10-29
|
AUT
| 9
|
child
|
Unknown
| 46.2
|
Cardiomax
|
Infection
|
Ophthalmic
| 10
|
mg
|
Four times daily
| null |
Low WBC
|
Agranulocytosis
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 13
| 7
|
Non-serious
|
Not recovered/Not resolved
|
Dose increased
|
Not applicable
|
Not applicable
|
Acetaminophen; Warfarin
|
Gastroesophageal reflux disease
|
Lawyer
|
Spontaneous
|
Possible
| 34
| 31
| 0.9
| 1.2
| null |
4EF830077EAB9CC6
|
2023-11-19
|
RUS
| 21
|
adult
|
Male
| 76.5
|
Diabecontrol
|
Rheumatoid arthritis
|
Topical
| 5
|
mg
|
Four times daily
| 259
|
Hepatocellular injury
|
Hepatotoxicity
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 24
| 70
|
Hospitalization - initial or prolonged
|
Recovered/Resolved
|
Drug withdrawn
|
Unknown
|
Not applicable
| null | null |
Pharmacist
|
Spontaneous
|
Possible
| 120
| null | 10.5
| 0.8
| 19
|
57C98C2AA1EA87E7
|
2024-11-12
|
POL
| 53
|
adult
|
Unknown
| null |
Psychostabil
|
Migraine prophylaxis
|
Subcutaneous
| 1
|
mg
|
As needed
| 708
|
Acute leukemia
|
Acute myeloid leukaemia
|
Leukaemias NEC
|
Malignant neoplasms
|
Neoplasms benign, malignant and unspecified
| 23
| 39
|
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Unknown
|
Not applicable
|
Albuterol; Hydrochlorothiazide
|
Anxiety disorder
|
Physician
|
Spontaneous
|
Possible
| null | 23
| 0.2
| 1
| null |
FBC0C579BD045CEF
|
2024-03-06
|
JPN
| 80
|
elderly
|
Unknown
| null |
Diabecontrol
|
GERD
|
Intravenous
| 250
|
mg
|
Four times daily
| 250
|
Cannot sleep
|
Anxiety
|
Depressive disorders
|
Mental disorders NEC
|
Psychiatric disorders
| 22
| null |
Disability
|
Recovered with sequelae
|
Drug withdrawn
|
Positive
|
Not applicable
|
Acetaminophen
|
Gastroesophageal reflux disease; Migraine
|
Physician
|
Spontaneous
|
Probable/Likely
| null | 33
| null | 0.9
| 14
|
A5BDDF88AE65A095
|
2024-01-13
|
SWE
| 51
|
adult
|
Unknown
| 79.8
|
Diabecontrol
|
Osteoarthritis
|
Rectal
| 5
|
mg
|
Three times daily
| 258
|
Convulsion
|
Headache
|
Headaches
|
Neurological disorders NEC
|
Nervous system disorders
| 7
| null |
Congenital anomaly
|
Unknown
|
Dose not changed
|
Not applicable
|
Not applicable
| null |
Gastroesophageal reflux disease; Benign prostatic hyperplasia
|
Consumer
|
Regulatory authority
|
Possible
| 43
| 13
| 0.4
| 0.8
| 9
|
6C88310FB016B892
|
2021-05-07
|
RUS
| 20
|
adult
|
Female
| 69.9
|
Diabecontrol
|
Anxiety
|
Oral
| 50
|
mg
|
Four times daily
| null |
DILI
|
Jaundice
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 3
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Atorvastatin; Hydrochlorothiazide; Prednisone
|
Occupational chemical exposure; Previous myocardial infarction
|
Pharmacist
|
Clinical trial
|
Probable/Likely
| 489
| 543
| 9.4
| null | null |
772C929AC2342465
|
2021-08-20
|
DNK
| 26
|
adult
|
Unknown
| 78.6
|
Painaway
|
COPD
|
Oral
| 25
|
mg
|
Three times daily
| 724
|
Vomiting symptom
|
Gastrointestinal haemorrhage
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 147
| 10
|
Non-serious
|
Recovered with sequelae
|
Dose not changed
|
Not applicable
|
Not applicable
|
Amoxicillin; Metoprolol
|
Migraine
|
Pharmacist
|
Spontaneous
|
Unlikely
| 27
| null | 1
| 1.2
| null |
409F47B4A2E65357
|
2024-03-11
|
JPN
| 13
|
adolescent
|
Unknown
| 73.1
|
Cardiomax
|
Hyperlipidemia
|
Subcutaneous
| 25
|
mg
|
As needed
| 22
|
CVA
|
Stroke
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 178
| null |
Non-serious
|
Recovered/Resolved
|
Dose increased
|
Not applicable
|
Not applicable
|
Furosemide
|
Osteoporosis
|
Lawyer
|
Spontaneous
|
Unlikely
| 41
| 25
| 0.5
| 1.2
| 18
|
19C30D76AA6B6C45
|
2024-01-23
|
POL
| 26
|
adult
|
Male
| null |
Thyroregul
|
Coronary artery disease
|
Topical
| 1
|
mg
|
Twice daily
| null |
Low hemoglobin
|
Anemia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 158
| 81
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Simvastatin; Atorvastatin
| null |
Consumer
|
Clinical trial
|
Possible
| 20
| 10
| 0.2
| 1.2
| 8
|
A72FAEBA9BD08C38
|
2023-03-25
|
MEX
| 47
|
adult
|
Male
| 82
|
Hematocare
|
Schizophrenia
|
Sublingual
| 2
|
mg
|
Once daily
| 283
|
Wheezing
|
Dyspnoea
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 26
| null |
Death
|
Fatal
|
Drug withdrawn
|
Positive
|
Not applicable
|
Simvastatin; Omeprazole; Losartan
|
Anxiety disorder; Depression
|
Consumer
|
Clinical trial
|
Probable/Likely
| 34
| 20
| null | 0.9
| null |
44F4DA6CA2153492
|
2021-07-25
|
BEL
| 70
|
elderly
|
Male
| 117.5
|
Lipidlow
|
Rheumatoid arthritis
|
Intravenous
| 500
|
mg
|
Once daily
| 539
|
Generalized anxiety
|
Insomnia
|
Depressive disorders
|
Mental disorders NEC
|
Psychiatric disorders
| 5
| 53
|
Non-serious
|
Unknown
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Acetaminophen
|
Previous stroke; Hyperlipidemia
|
Other health professional
|
Literature
|
Possible
| 44
| 20
| 1.1
| 1
| 10
|
ABAB4B3427295CC2
|
2023-01-15
|
ZAF
| 25
|
adult
|
Female
| 61.6
|
Cardiomax
|
Type 2 diabetes
|
Inhalation
| 1
|
mg
|
Three times daily
| null |
Decreased blood cells
|
Pancytopenia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 8
| 68
|
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Positive
|
Not applicable
|
Amoxicillin
|
Hepatitis C
|
Consumer
|
Spontaneous
|
Probable/Likely
| 39
| 24
| 0.1
| 1.2
| null |
27FD1578D123F555
|
2025-09-11
|
FRA
| 36
|
adult
|
Female
| 120
|
Pulmofix
|
Migraine prophylaxis
|
Ophthalmic
| 5
|
mg
|
As needed
| 303
|
Loose stools
|
Diarrhoea
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 27
| null |
Non-serious
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Metformin; Acetaminophen
|
Smoking history; Hepatitis B
|
Other health professional
|
Clinical trial
|
Possible
| 24
| null | 0.3
| 1.1
| 17
|
6F3EB8ACAB09E582
|
2021-06-07
|
IND
| 63
|
adult
|
Female
| 56.3
|
Eyeprotect
|
Atrial fibrillation
|
Intramuscular
| 2
|
mg
| null | 553
|
Decreased RBC
|
Thrombocytopenia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 30
| 35
|
Non-serious
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Insulin
|
Depression; Occupational chemical exposure
|
Physician
|
Spontaneous
|
Possible
| null | null | 0.8
| 0.9
| 15
|
BDE02EA4D5241E3D
|
2023-08-23
|
FRA
| 56
|
adult
|
Female
| 107.6
|
Dermafix
|
GERD
|
Rectal
| 1
|
mg
| null | 575
|
Blood in stool
|
Nausea
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 407
| null |
Disability
|
Recovered with sequelae
|
Dose reduced
|
Not applicable
|
Not applicable
|
Omeprazole
| null |
Physician
|
Spontaneous
|
Unlikely
| null | 17
| 0.2
| 1.1
| 15
|
E1FCEEC20570540D
|
2025-10-13
|
RUS
| 33
|
adult
|
Male
| 98.3
|
Vasodilate
|
GERD
|
Inhalation
| 1
|
mg
|
Three times daily
| null |
Basal cell carcinoma
|
Lymphoma
|
Leukaemias NEC
|
Malignant neoplasms
|
Neoplasms benign, malignant and unspecified
| 13
| 36
|
Death
|
Fatal
|
Unknown
|
Not applicable
|
Not applicable
|
Lisinopril; Amoxicillin
|
Previous stroke
|
Consumer
|
Regulatory authority
|
Possible
| 13
| 17
| null | 1.2
| null |
11927E0309C1CBAC
|
2025-03-16
|
FRA
| 68
|
elderly
|
Male
| 87.8
|
Dermafix
|
Hypertension
|
Intramuscular
| 1
|
mg
| null | 244
|
Eosinophilia
|
Drug reaction with eosinophilia
|
Hypersensitivity conditions NEC
|
Allergic conditions
|
Immune system disorders
| 6
| 34
|
Other medically important condition
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Pantoprazole
| null |
Consumer
|
Spontaneous
|
Probable/Likely
| 12
| 39
| 0.7
| null | 14
|
FA8D3B8951A3D545
|
2024-11-10
|
FIN
| 25
|
adult
|
Unknown
| 58.8
|
Lipidlow
|
Hypothyroidism
|
Inhalation
| 10
|
mg
| null | null |
Loose stools
|
Diarrhoea
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 20
| 56
|
Other medically important condition
|
Recovered/Resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Hydrochlorothiazide; Ciprofloxacin
|
Rheumatoid arthritis; Obesity; Hepatitis B
|
Pharmacist
|
Spontaneous
|
Possible
| 39
| null | 0.6
| null | null |
6DCE6F0EAA6CFE42
|
2025-09-25
|
FRA
| 57
|
adult
|
Unknown
| null |
Infectoban
|
Osteoarthritis
|
Topical
| 1
|
mg
|
Three times daily
| 615
|
Cramping
|
Diarrhoea
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 19
| 65
|
Other medically important condition
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Hydrochlorothiazide
|
Occupational radiation exposure
|
Other health professional
|
Spontaneous
|
Possible
| 37
| 34
| 0.8
| 0.6
| 20
|
353ED98700262A43
|
2024-08-08
|
ITA
| 29
|
adult
|
Male
| null |
Eyeprotect
|
Bipolar disorder
|
Oral
| 10
|
mg
|
As needed
| 221
|
Cytopenia
|
Leukopenia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 11
| 21
|
Non-serious
|
Not recovered/Not resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Lisinopril
|
Atrial fibrillation; Chronic kidney disease; Occupational radiation exposure
|
Consumer
|
Spontaneous
|
Possible
| 15
| 31
| 0.8
| 0.8
| 12
|
03786152A65949A9
|
2022-10-28
|
CAN
| 54
|
adult
|
Female
| null |
Sleepwell
|
Depression
|
Transdermal
| 5
|
mg
|
Three times daily
| 123
|
CHF
|
Cardiac failure
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 14
| 23
|
Congenital anomaly
|
Not recovered/Not resolved
|
Dose increased
|
Not applicable
|
Not applicable
|
Albuterol; Lisinopril
|
Benign prostatic hyperplasia
|
Physician
|
Spontaneous
|
Possible
| 39
| 37
| 0.6
| 1
| null |
D52AF8B08D66FB20
|
2025-02-26
|
MEX
| 16
|
adolescent
|
Unknown
| 50.9
|
Anticoag-XR
|
Hyperlipidemia
|
Topical
| 5
|
mg
|
Three times daily
| 227
|
Low neutrophils
|
Pancytopenia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 50
| 66
|
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Ibuprofen
|
COPD; Coronary artery disease; Atrial fibrillation
|
Other health professional
|
Spontaneous
|
Unlikely
| 19
| null | 1.1
| 0.9
| 16
|
3E7BD717FF124F0E
|
2021-11-21
|
FIN
| 28
|
adult
|
Female
| 54.8
|
Oncotreat
|
Asthma
|
Ophthalmic
| 1
|
mg
|
Three times daily
| null |
Hepatic dysfunction
|
Hepatic failure
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 15
| 5
|
Hospitalization - initial or prolonged
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Acetaminophen; Clopidogrel
|
Osteoporosis
|
Consumer
|
Regulatory authority
|
Possible
| 142
| 675
| 5.8
| null | 8
|
5E515EA76957E281
|
2024-07-19
|
BRA
| 48
|
adult
|
Male
| 86.6
|
Arthrorelief
|
COPD
|
Topical
| 10
|
mg
|
Three times daily
| null |
Septic shock
|
Sepsis
|
Bacterial infections NEC
|
Infections NEC
|
Infections and infestations
| 21
| 83
|
Hospitalization - initial or prolonged
|
Recovered/Resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Ciprofloxacin
|
Hepatitis C; Previous myocardial infarction; Alcohol use disorder
|
Pharmacist
|
Spontaneous
|
Possible
| 19
| 19
| 0.9
| 1
| 11
|
668DE02B9761605D
|
2024-12-09
|
CHN
| 95
|
elderly
|
Unknown
| 56.5
|
Anticoag-XR
|
Osteoarthritis
|
Oral
| 100
|
mg
|
Three times daily
| 185
|
Erythema multiforme
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 25
| 63
|
Life-threatening
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Hydrochlorothiazide
|
Hepatitis B; Chronic pain; Diabetes mellitus type 2
|
Other health professional
|
Literature
|
Possible
| 18
| null | 1
| null | null |
F8A93FECC5A98328
|
2021-01-20
|
ZAF
| 74
|
elderly
|
Female
| 66.7
|
Hematocare
|
Osteoarthritis
|
Ophthalmic
| 10
|
mg
|
Four times daily
| 289
|
Shortness of breath
|
Respiratory failure
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 14
| null |
Non-serious
|
Not recovered/Not resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Hydrochlorothiazide; Atorvastatin
|
Chronic pain; Alcohol use disorder
|
Physician
|
Spontaneous
|
Probable/Likely
| 20
| 38
| null | 1.2
| 12
|
B16C43B9E05EE8CC
|
2025-07-11
|
IND
| 36
|
adult
|
Unknown
| 108.7
|
Neurobalance
|
Depression
|
Oral
| 50
|
mg
|
Four times daily
| null |
Oliguria
|
Acute kidney injury
|
Acute renal failures
|
Renal failures and impairments
|
Renal and urinary disorders
| 151
| null |
Non-serious
|
Recovered with sequelae
|
Drug withdrawn
|
Positive
|
Unknown
|
Prednisone; Atorvastatin
|
COPD; Hypothyroidism
|
Physician
|
Spontaneous
|
Possible
| 36
| 29
| 0.2
| null | 90
|
ED35BFC66A9EF391
|
2023-11-07
|
DEU
| 58
|
adult
|
Female
| null |
Anticoag-XR
|
Hypothyroidism
|
Sublingual
| 25
|
mg
| null | 21
|
SOB
|
Pneumonitis
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 42
| 21
|
Non-serious
|
Recovered/Resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Lisinopril
|
Benign prostatic hyperplasia
|
Physician
|
Clinical trial
|
Unlikely
| null | 21
| null | 1.1
| 18
|
7F22EE40E9747174
|
2024-10-25
|
BEL
| 28
|
adult
|
Female
| null |
Psychostabil
|
Hypothyroidism
|
Rectal
| 5
|
mg
|
Once daily
| 663
|
Hives
|
Urticaria
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 28
| 7
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Gabapentin; Levothyroxine
|
Sleep apnea; Peripheral vascular disease; Anxiety disorder; Hepatitis C
|
Consumer
|
Spontaneous
|
Probable/Likely
| 15
| 12
| null | null | 12
|
937A3483B70E66A1
|
2023-03-14
|
FIN
| 9
|
child
|
Female
| null |
Hepatosan
|
Hyperlipidemia
|
Topical
| 5
|
mg
|
As needed
| 696
|
Skin rash
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 327
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Pantoprazole
| null |
Pharmacist
|
Spontaneous
|
Possible
| 33
| null | 0.3
| 0.8
| null |
1E76B4CE76D8D58A
|
2025-04-11
|
CAN
| 33
|
adult
|
Female
| 70
|
Dermatopin
|
Depression
|
Intravenous
| 500
|
mg
|
Twice daily
| null |
Mixed hepatic injury
|
Hepatitis acute
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 112
| null |
Death
|
Fatal
|
Dose increased
|
Not applicable
|
Not applicable
|
Insulin
|
Peripheral vascular disease; Hepatitis C; Previous stroke
|
Pharmacist
|
Clinical trial
|
Unlikely
| null | 295
| 4.7
| 0.9
| 14
|
AADDD20E42CBAAFD
|
2023-07-01
|
DEU
| 52
|
adult
|
Unknown
| null |
Neurobalance
|
Rheumatoid arthritis
|
Intravenous
| 500
|
mg
|
Four times daily
| 697
|
Muscle fatigue
|
Rhabdomyolysis
|
Myopathies
|
Muscle disorders
|
Musculoskeletal and connective tissue disorders
| 29
| null |
Non-serious
|
Recovered/Resolved
|
Unknown
|
Not applicable
|
Not applicable
|
Metformin
|
Chronic pain; Atrial fibrillation; Hypothyroidism
|
Pharmacist
|
Spontaneous
|
Possible
| 24
| 40
| null | 0.7
| null |
A5EFF1ED7A43BCE5
|
2022-08-25
|
IND
| 62
|
adult
|
Unknown
| 100.4
|
Lipidlow
|
Type 2 diabetes
|
Oral
| 10
|
mg
|
Once daily
| 657
|
Facial swelling
|
Angioedema
|
Hypersensitivity conditions NEC
|
Allergic conditions
|
Immune system disorders
| 7
| 74
|
Non-serious
|
Recovering/Resolving
|
Dose reduced
|
Not applicable
|
Not applicable
|
Insulin; Ibuprofen
|
Sleep apnea; COPD; Occupational chemical exposure; Heart failure
|
Lawyer
|
Spontaneous
|
Possible
| 14
| 15
| null | 1
| 18
|
7D63D54087253868
|
2025-07-18
|
AUS
| 14
|
adolescent
|
Female
| 45.5
|
Neurobalance
|
Pain management
|
Oral
| 50
|
mg
|
Four times daily
| 631
|
Bronchial constriction
|
Respiratory failure
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 28
| null |
Non-serious
|
Recovered with sequelae
|
Dose not changed
|
Not applicable
|
Not applicable
| null |
Chronic pain
|
Lawyer
|
Spontaneous
|
Possible
| 29
| 12
| 0.7
| 0.8
| 7
|
4469ED65369AF93A
|
2020-12-17
|
BRA
| 13
|
adolescent
|
Female
| 72.7
|
Hepatosan
|
Migraine prophylaxis
|
Oral
| 1,000
|
mg
|
Twice daily
| null |
Hyperthyroidism
|
Diabetes mellitus
|
Hyperglycaemic conditions NEC
|
Glucose metabolism disorders
|
Endocrine disorders
| 13
| 65
|
Non-serious
|
Recovering/Resolving
|
Not applicable
|
Not applicable
|
Not applicable
|
Acetaminophen; Atorvastatin
| null |
Physician
|
Spontaneous
|
Possible
| 31
| 21
| 0.3
| null | 9
|
CEADD96423260391
|
2021-11-28
|
CHE
| 74
|
elderly
|
Unknown
| null |
Oncotreat
|
Seizure disorder
|
Inhalation
| 25
|
mg
|
As needed
| null |
Elevated CPK
|
Back pain
|
Myopathies
|
Muscle disorders
|
Musculoskeletal and connective tissue disorders
| 107
| null |
Non-serious
|
Recovered/Resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Pantoprazole; Insulin; Ciprofloxacin
|
Previous stroke; Hypertension; Previous myocardial infarction
|
Lawyer
|
Spontaneous
|
Unlikely
| 24
| 28
| 0.7
| 1.1
| 20
|
FB7454AF6380AF6B
|
2023-07-29
|
NZL
| 61
|
adult
|
Unknown
| 78.7
|
Painaway
|
Stroke prevention
|
Oral
| 20
|
mg
|
As needed
| 213
|
Anaphylactic shock
|
Anaphylactic reaction
|
Hypersensitivity conditions NEC
|
Allergic conditions
|
Immune system disorders
| 22
| 62
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Unknown
|
Not applicable
|
Albuterol
|
Alcohol use disorder; Benign prostatic hyperplasia
|
Other health professional
|
Spontaneous
|
Possible
| 22
| 18
| 0.3
| 0.8
| 10
|
30000BCEFBB1E0D9
|
2025-10-13
|
TUR
| 56
|
adult
|
Female
| null |
Arthrorelief
|
Infection
|
Intramuscular
| 5
|
mg
|
Once daily
| 295
|
Hepatocellular injury
|
Hepatotoxicity
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 15
| 84
|
Disability
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Hydrochlorothiazide
|
Atrial fibrillation; Coronary artery disease
|
Consumer
|
Clinical trial
|
Possible
| null | null | null | 0.8
| 17
|
9AEB86F5B864388B
|
2025-02-02
|
IND
| 79
|
elderly
|
Female
| null |
Oncotreat
|
Bipolar disorder
|
Oral
| 10
|
mg
|
As needed
| null |
Low blood sugar
|
Thyroid disorder
|
Hyperglycaemic conditions NEC
|
Glucose metabolism disorders
|
Endocrine disorders
| 40
| 23
|
Non-serious
|
Not recovered/Not resolved
|
Unknown
|
Not applicable
|
Not applicable
| null |
Occupational chemical exposure; Sleep apnea; Chronic kidney disease
|
Other health professional
|
Literature
|
Possible
| 10
| null | 1.2
| 1.3
| 14
|
B3BD1928E414F658
|
2025-06-28
|
CHE
| 59
|
adult
|
Male
| 100.3
|
Diabecontrol
|
COPD
|
Ophthalmic
| 2
|
mg
|
Twice daily
| 626
|
Non-Hodgkin lymphoma
|
Acute myeloid leukaemia
|
Leukaemias NEC
|
Malignant neoplasms
|
Neoplasms benign, malignant and unspecified
| 140
| 66
|
Disability
|
Recovering/Resolving
|
Drug withdrawn
|
Positive
|
Not applicable
|
Furosemide
|
Obesity
|
Other health professional
|
Regulatory authority
|
Possible
| 29
| null | 0.8
| null | null |
2B89D9B20E213E3A
|
2024-12-31
|
ITA
| 36
|
adult
|
Male
| null |
Painaway
|
Depression
|
Rectal
| 25
|
mg
|
Three times daily
| null |
Hypothyroidism
|
Thyroid disorder
|
Hyperglycaemic conditions NEC
|
Glucose metabolism disorders
|
Endocrine disorders
| 956
| 69
|
Non-serious
|
Not recovered/Not resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Acetaminophen; Lisinopril
|
Chronic pain; Peripheral vascular disease
|
Other health professional
|
Spontaneous
|
Unlikely
| null | 27
| 0.3
| 0.7
| null |
5333134178EA57DC
|
2025-06-12
|
SWE
| 51
|
adult
|
Male
| 82
|
Vasodilate
|
Cancer
|
Transdermal
| 1
|
mg
|
Four times daily
| 261
|
Heart failure
|
Cardiac failure
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 179
| 10
|
Hospitalization - initial or prolonged
|
Not recovered/Not resolved
|
Dose increased
|
Not applicable
|
Not applicable
| null |
Hepatitis C; Sleep apnea; Diabetes mellitus type 2
|
Other health professional
|
Spontaneous
|
Possible
| 18
| 33
| 0.6
| 0.9
| 13
|
957326EA46B40FB4
|
2022-10-05
|
AUS
| 53
|
adult
|
Unknown
| null |
Cardiomax
|
Infection
|
Oral
| 50
|
mg
|
Four times daily
| null |
Thyroid dysfunction
|
Thyroid disorder
|
Hyperglycaemic conditions NEC
|
Glucose metabolism disorders
|
Endocrine disorders
| 13
| 30
|
Hospitalization - initial or prolonged
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Metformin; Amoxicillin
|
Occupational radiation exposure
|
Physician
|
Spontaneous
|
Possible
| null | 11
| 0.8
| null | null |
3EF675D049109158
|
2022-09-01
|
PRT
| 90
|
elderly
|
Unknown
| null |
Dermafix
|
Rheumatoid arthritis
|
Subcutaneous
| 5
|
mg
|
Twice daily
| null |
Weakness
|
Rhabdomyolysis
|
Myopathies
|
Muscle disorders
|
Musculoskeletal and connective tissue disorders
| 10
| 36
|
Congenital anomaly
|
Recovered with sequelae
|
Unknown
|
Not applicable
|
Not applicable
|
Prednisone; Hydrochlorothiazide
|
Anxiety disorder
|
Lawyer
|
Clinical trial
|
Possible
| 30
| null | 0.5
| 0.9
| 11
|
FD9A5886A483DFC5
|
2024-02-19
|
FIN
| 41
|
adult
|
Female
| 67.8
|
Nephroguard
|
Coronary artery disease
|
Inhalation
| 1
|
mg
|
As needed
| 196
|
Bradycardia
|
Cardiac failure
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 22
| null |
Non-serious
|
Recovered with sequelae
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Hydrochlorothiazide; Metoprolol
|
Alcohol use disorder
|
Other health professional
|
Spontaneous
|
Possible
| null | 16
| 0.2
| null | 16
|
89EC5E64989D1E01
|
2021-12-26
|
RUS
| 37
|
adult
|
Female
| 75.2
|
Dermatopin
|
Stroke prevention
|
Rectal
| 5
|
mg
| null | 380
|
Hard stools
|
Gastrointestinal haemorrhage
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 19
| null |
Non-serious
|
Recovered/Resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Ciprofloxacin
|
Atrial fibrillation
|
Pharmacist
|
Spontaneous
|
Possible
| 34
| 17
| 0.8
| 0.8
| 18
|
50F637EECF1F3D2B
|
2021-02-19
|
TUR
| 50
|
adult
|
Male
| null |
Dermafix
|
Type 2 diabetes
|
Oral
| 200
|
mg
| null | null |
Convulsion
|
Headache
|
Headaches
|
Neurological disorders NEC
|
Nervous system disorders
| 5
| 2
|
Disability
|
Recovered/Resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Acetaminophen; Simvastatin
|
Hypertension; Migraine
|
Consumer
|
Spontaneous
|
Possible
| 11
| 18
| 0.4
| 1.1
| null |
70A636595BCAFC00
|
2022-10-31
|
RUS
| 41
|
adult
|
Female
| 76.1
|
Lipidlow
|
GERD
|
Subcutaneous
| 5
|
mg
| null | 670
|
High blood pressure
|
Deep vein thrombosis
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 54
| null |
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Positive
|
Positive
|
Levothyroxine
|
Alcohol use disorder; Coronary artery disease
|
Consumer
|
Literature
|
Certain
| null | 37
| 0.7
| 1.2
| 11
|
14F99AE4E4B593CC
|
2021-06-16
|
ESP
| 64
|
adult
|
Female
| 115
|
Lipidlow
|
GERD
|
Ophthalmic
| 10
|
mg
|
As needed
| null |
Breathing difficulty
|
Pulmonary embolism
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 66
| 89
|
Non-serious
|
Recovering/Resolving
|
Unknown
|
Not applicable
|
Not applicable
| null |
Smoking history
|
Physician
|
Spontaneous
|
Possible
| 35
| null | 0.4
| 0.9
| 13
|
91C416DEA5553E44
|
2023-10-08
|
GRC
| 23
|
adult
|
Unknown
| 60.8
|
Osteostrong
|
Depression
|
Topical
| 5
|
mg
|
Three times daily
| null |
Elevated transaminases
|
Hepatotoxicity
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 10
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Prednisone
| null |
Physician
|
Spontaneous
|
Probable/Likely
| 195
| 422
| 1.7
| 1.1
| 15
|
DDB6705FBDFE7BD6
|
2025-02-01
|
JPN
| 48
|
adult
|
Female
| 54.4
|
Infectoban
|
COPD
|
Rectal
| 1
|
mg
|
Three times daily
| 258
|
Light-headedness
|
Seizure
|
Headaches
|
Neurological disorders NEC
|
Nervous system disorders
| 157
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Gabapentin; Levothyroxine
|
Rheumatoid arthritis
|
Consumer
|
Spontaneous
|
Possible
| 30
| null | 0.4
| 1.3
| 18
|
9CA35463ED5A8CFE
|
2025-10-25
|
ESP
| 53
|
adult
|
Unknown
| 91.5
|
Dermafix
|
Infection
|
Sublingual
| 1
|
mg
|
Four times daily
| 726
|
Skin peeling
|
Pruritus
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 10
| null |
Disability
|
Recovering/Resolving
|
Drug withdrawn
|
Positive
|
Not applicable
| null |
Osteoarthritis
|
Physician
|
Spontaneous
|
Probable/Likely
| 40
| 27
| 1.1
| 1
| 12
|
9DF41A45AEFCAB99
|
2024-12-24
|
POL
| 30
|
adult
|
Unknown
| null |
Osteostrong
|
Migraine prophylaxis
|
Inhalation
| 10
|
mg
| null | 11
|
Yellow skin
|
Jaundice
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 17
| 9
|
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Positive
|
Not applicable
|
Azithromycin; Clopidogrel
|
Hypertension
|
Lawyer
|
Spontaneous
|
Probable/Likely
| 525
| null | null | 0.8
| 10
|
DE41841676D12418
|
2021-10-13
|
FRA
| 1
|
child
|
Unknown
| null |
Dermafix
|
Anxiety
|
Subcutaneous
| 25
|
mg
|
Twice daily
| null |
Skin rash
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 14
| 60
|
Disability
|
Recovering/Resolving
|
Drug withdrawn
|
Negative
|
Not applicable
|
Ciprofloxacin
|
Asthma; Obesity
|
Consumer
|
Spontaneous
|
Unlikely
| 10
| 16
| 0.9
| 1
| null |
6F5AD8AF068AD6F2
|
2024-06-15
|
FRA
| 57
|
adult
|
Unknown
| null |
Arthrorelief
|
Osteoarthritis
|
Rectal
| 25
|
mg
|
Twice daily
| null |
Watery stools
|
Diarrhoea
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 785
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
| null |
Previous myocardial infarction
|
Pharmacist
|
Spontaneous
|
Possible
| null | 30
| 1.1
| null | null |
201BEA405C92AAF7
|
2021-10-17
|
FIN
| 19
|
adolescent
|
Unknown
| 117.5
|
Painaway
|
Atrial fibrillation
|
Rectal
| 10
|
mg
|
Four times daily
| null |
SJS
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 1
| 29
|
Hospitalization - initial or prolonged
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Simvastatin
|
Coronary artery disease; Osteoporosis
|
Physician
|
Spontaneous
|
Possible
| 44
| 21
| 0.9
| null | null |
A2BDEA67E37F41F5
|
2021-11-20
|
PRT
| 24
|
adult
|
Male
| 110.6
|
Pulmofix
|
Insomnia
|
Ophthalmic
| 5
|
mg
| null | 648
|
Blood clot in lung
|
Pulmonary embolism
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 5
| null |
Non-serious
|
Not recovered/Not resolved
|
Dose not changed
|
Not applicable
|
Not applicable
|
Acetaminophen
|
Depression; Peripheral vascular disease
|
Other health professional
|
Spontaneous
|
Possible
| 27
| 26
| null | 1.3
| 7
|
F5B347856E8CCB0E
|
2024-10-09
|
FIN
| 90
|
elderly
|
Unknown
| null |
Immunoshield
|
Bipolar disorder
|
Topical
| 10
|
mg
|
Four times daily
| 78
|
New malignancy
|
Carcinoma
|
Leukaemias NEC
|
Malignant neoplasms
|
Neoplasms benign, malignant and unspecified
| 54
| null |
Non-serious
|
Recovered/Resolved
|
Unknown
|
Not applicable
|
Not applicable
|
Simvastatin
|
Hypertension
|
Physician
|
Clinical trial
|
Unlikely
| 39
| 32
| 0.2
| 0.8
| 10
|
627200A91C8E661A
|
2024-11-22
|
GRC
| 91
|
elderly
|
Unknown
| null |
Vasodilate
|
Hypertension
|
Intravenous
| 100
|
mg
|
Four times daily
| null |
Heart failure
|
Cardiac failure
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 619
| 26
|
Non-serious
|
Recovered with sequelae
|
Not applicable
|
Not applicable
|
Not applicable
|
Furosemide
| null |
Other health professional
|
Spontaneous
|
Unlikely
| 33
| null | 0.5
| null | null |
F70365BF2ACAF087
|
2024-09-22
|
AUT
| 18
|
adult
|
Female
| 107.2
|
Neurobalance
|
Heart failure
|
Intravenous
| 100
|
mg
|
Four times daily
| 92
|
Jaundice symptom
|
Drug-induced liver injury
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 12
| null |
Life-threatening
|
Recovering/Resolving
|
Dose not changed
|
Not applicable
|
Not applicable
| null |
Previous myocardial infarction; Previous stroke
|
Pharmacist
|
Spontaneous
|
Possible
| 318
| 245
| 9.8
| 0.8
| 9
|
D3E7D7BC23D3B753
|
2021-10-16
|
CHE
| 22
|
adult
|
Unknown
| null |
Glucobalance
|
COPD
|
Oral
| 50
|
mg
|
Twice daily
| 531
|
UTI
|
Urinary tract infection
|
Bacterial infections NEC
|
Infections NEC
|
Infections and infestations
| 24
| null |
Death
|
Fatal
|
Dose not changed
|
Not applicable
|
Not applicable
|
Warfarin; Simvastatin
|
COPD
|
Lawyer
|
Spontaneous
|
Possible
| 14
| 10
| null | 1.2
| 12
|
AC0D5C4253EC96BD
|
2021-01-30
|
GRC
| 1
|
infant
|
Male
| null |
Psychostabil
|
Chronic kidney disease
|
Transdermal
| 25
|
mg
|
Four times daily
| 434
|
Lung inflammation
|
Dyspnoea
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 18
| null |
Non-serious
|
Recovered/Resolved
|
Dose reduced
|
Not applicable
|
Not applicable
|
Metoprolol
|
Atrial fibrillation; Migraine; Depression; Osteoarthritis
|
Consumer
|
Spontaneous
|
Possible
| 14
| 23
| null | 0.7
| 14
|
26B0B99A09EAA0CC
|
2022-12-20
|
BEL
| 11
|
adolescent
|
Female
| 29.9
|
Anticoag-XR
|
Stroke prevention
|
Transdermal
| 2
|
mg
|
Three times daily
| 130
|
Fainting
|
Headache
|
Headaches
|
Neurological disorders NEC
|
Nervous system disorders
| 61
| null |
Disability
|
Recovered/Resolved
|
Drug withdrawn
|
Negative
|
Not applicable
|
Lisinopril
|
Chronic pain
|
Other health professional
|
Spontaneous
|
Unlikely
| 20
| 18
| 1.1
| 0.7
| null |
A7B6846198108FAC
|
2022-10-11
|
CHE
| 90
|
elderly
|
Unknown
| 88.7
|
Osteostrong
|
Atrial fibrillation
|
Subcutaneous
| 5
|
mg
|
Twice daily
| 427
|
Difficulty defecating
|
Gastrointestinal haemorrhage
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 3
| null |
Non-serious
|
Recovering/Resolving
|
Unknown
|
Not applicable
|
Not applicable
| null |
Diabetes mellitus type 2; Osteoarthritis; Hyperlipidemia
|
Lawyer
|
Literature
|
Possible
| 29
| 27
| 0.5
| 1.1
| 10
|
3BF5D05671C2815E
|
2022-05-11
|
USA
| 71
|
elderly
|
Female
| 50.4
|
Pulmofix
|
Hypothyroidism
|
Inhalation
| 1
|
mg
| null | 2
|
Low blood pressure
|
Hypertension
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 24
| null |
Congenital anomaly
|
Unknown
|
Dose reduced
|
Not applicable
|
Not applicable
|
Omeprazole; Azithromycin; Furosemide
| null |
Pharmacist
|
Literature
|
Possible
| 43
| 38
| null | null | 20
|
6C26F26EAB47642A
|
2023-03-19
|
IND
| 95
|
elderly
|
Unknown
| null |
Diabecontrol
|
Coronary artery disease
|
Transdermal
| 2
|
mg
| null | null |
Elevated creatinine
|
Renal impairment
|
Acute renal failures
|
Renal failures and impairments
|
Renal and urinary disorders
| 180
| null |
Life-threatening
|
Recovered/Resolved
|
Dose reduced
|
Not applicable
|
Not applicable
| null |
Occupational radiation exposure
|
Pharmacist
|
Spontaneous
|
Possible
| 39
| null | 1
| 6.1
| 52
|
0AA9692ECFF9B273
|
2023-05-21
|
ISR
| 33
|
adult
|
Female
| 52.2
|
Vasodilate
|
Hypothyroidism
|
Sublingual
| 2
|
mg
|
Once daily
| 474
|
Jaundice symptom
|
Drug-induced liver injury
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 66
| 16
|
Life-threatening
|
Recovered/Resolved
|
Not applicable
|
Not applicable
|
Not applicable
|
Ibuprofen
|
Hyperlipidemia; Osteoporosis; Gastroesophageal reflux disease
|
Physician
|
Spontaneous
|
Unlikely
| null | 544
| 2.7
| null | null |
62BE3BD015D18472
|
2025-09-07
|
JPN
| 39
|
adult
|
Female
| null |
Vasodilate
|
Depression
|
Oral
| 25
|
mg
|
Three times daily
| 511
|
Productive cough
|
Pneumonitis
|
Dyspnoea and related conditions
|
Respiratory disorders NEC
|
Respiratory, thoracic and mediastinal disorders
| 153
| 8
|
Disability
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Ibuprofen
|
Migraine; Occupational chemical exposure; Hypertension; Osteoarthritis
|
Other health professional
|
Spontaneous
|
Unlikely
| 41
| 28
| null | null | 19
|
A40510A9EEF7513B
|
2022-07-28
|
SWE
| 67
|
elderly
|
Female
| 96
|
Eyeprotect
|
Type 2 diabetes
|
Subcutaneous
| 25
|
mg
|
Four times daily
| 364
|
Erythematous rash
|
Dermatitis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 19
| null |
Non-serious
|
Recovering/Resolving
|
Unknown
|
Not applicable
|
Not applicable
| null |
Osteoporosis; Atrial fibrillation
|
Consumer
|
Regulatory authority
|
Possible
| 41
| 15
| null | 0.8
| 7
|
CAA451D756274CD1
|
2025-11-19
|
NZL
| 64
|
elderly
|
Unknown
| 60.3
|
Neurobalance
|
Infection
|
Intravenous
| 1,000
|
mg
|
Three times daily
| 75
|
Decreased blood cells
|
Pancytopenia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 132
| 13
|
Hospitalization - initial or prolonged
|
Recovered/Resolved
|
Drug withdrawn
|
Unknown
|
Not applicable
|
Simvastatin; Ibuprofen
|
Peripheral vascular disease
|
Consumer
|
Spontaneous
|
Unlikely
| null | 28
| 0.5
| null | 7
|
8E9BD130EC55CCD8
|
2023-08-17
|
NZL
| 56
|
adult
|
Male
| 94.8
|
Painaway
|
Depression
|
Inhalation
| 1
|
mg
|
Twice daily
| 356
|
Difficulty defecating
|
Gastrointestinal haemorrhage
|
Nausea and vomiting symptoms
|
Gastrointestinal signs and symptoms
|
Gastrointestinal disorders
| 29
| 12
|
Non-serious
|
Recovering/Resolving
|
Dose not changed
|
Not applicable
|
Not applicable
|
Aspirin
|
COPD
|
Physician
|
Spontaneous
|
Possible
| 16
| 11
| 0.9
| 1.2
| 13
|
88E417428472EAE3
|
2025-03-27
|
KOR
| 44
|
adult
|
Male
| null |
Cardiomax
|
Rheumatoid arthritis
|
Transdermal
| 1
|
mg
|
Once daily
| null |
TEN
|
Rash
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 72
| 10
|
Non-serious
|
Recovered with sequelae
|
Drug withdrawn
|
Positive
|
Not applicable
|
Aspirin
|
Previous stroke
|
Pharmacist
|
Spontaneous
|
Possible
| null | 13
| 1.2
| 1
| 15
|
662A831726332AA5
|
2021-06-10
|
TUR
| 39
|
adult
|
Female
| 79.9
|
Dermafix
|
Bipolar disorder
|
Ophthalmic
| 10
|
mg
|
Twice daily
| null |
Myocardial infarction
|
Cardiac failure
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 21
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Amoxicillin
|
Previous stroke
|
Consumer
|
Spontaneous
|
Possible
| 33
| null | 0.1
| 0.8
| null |
74268041C9F7CF42
|
2022-07-16
|
TUR
| 82
|
elderly
|
Female
| 88.8
|
Anticoag-XR
|
Atrial fibrillation
|
Sublingual
| 10
|
mg
|
As needed
| 242
|
Suicidal thoughts
|
Insomnia
|
Depressive disorders
|
Mental disorders NEC
|
Psychiatric disorders
| 13
| 5
|
Non-serious
|
Recovered with sequelae
|
Not applicable
|
Not applicable
|
Not applicable
|
Acetaminophen; Omeprazole
| null |
Lawyer
|
Spontaneous
|
Possible
| 20
| null | null | null | 20
|
5E225B62E71609D9
|
2022-12-16
|
BEL
| 45
|
adult
|
Female
| 72.8
|
Vasodilate
|
Hypertension
|
Ophthalmic
| 25
|
mg
|
As needed
| null |
Acute renal failure
|
Renal failure acute
|
Acute renal failures
|
Renal failures and impairments
|
Renal and urinary disorders
| 5
| 73
|
Non-serious
|
Not recovered/Not resolved
|
Unknown
|
Not applicable
|
Not applicable
|
Pantoprazole; Atorvastatin; Insulin
|
Hepatitis B; Anxiety disorder; Rheumatoid arthritis
|
Other health professional
|
Spontaneous
|
Possible
| 41
| null | null | 5.5
| 29
|
4C07091CDA18813C
|
2025-10-20
|
ISR
| 39
|
adult
|
Female
| null |
Urocare
|
Cancer
|
Intravenous
| 100
|
mg
| null | null |
Clinical depression
|
Hallucination
|
Depressive disorders
|
Mental disorders NEC
|
Psychiatric disorders
| 113
| null |
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Positive
|
Not applicable
|
Simvastatin
|
Alcohol use disorder; Anxiety disorder
|
Physician
|
Spontaneous
|
Possible
| null | 32
| 0.2
| null | 10
|
99A0575903ABA10A
|
2021-08-27
|
NZL
| 42
|
adult
|
Unknown
| 85.4
|
Dermatopin
|
Cancer
|
Oral
| 25
|
mg
| null | null |
Bacterial pneumonia
|
Urinary tract infection
|
Bacterial infections NEC
|
Infections NEC
|
Infections and infestations
| 28
| 61
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Azithromycin; Lisinopril
|
Osteoarthritis
|
Physician
|
Spontaneous
|
Possible
| 23
| null | 0.3
| 1
| 19
|
49EC66E68ACB2777
|
2025-05-28
|
ISR
| 37
|
adult
|
Female
| 79.7
|
Arthrorelief
|
Coronary artery disease
|
Transdermal
| 2
|
mg
|
Four times daily
| 310
|
Cerebrovascular accident
|
Hypertension
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 20
| 51
|
Non-serious
|
Recovered/Resolved
|
Unknown
|
Not applicable
|
Not applicable
|
Albuterol; Hydrochlorothiazide; Ibuprofen
|
Hypothyroidism; Heart failure
|
Physician
|
Spontaneous
|
Possible
| 31
| 30
| 0.4
| 1.3
| null |
593CCA96BA6C46F5
|
2023-08-19
|
NLD
| 60
|
adult
|
Unknown
| null |
Oncotreat
|
Asthma
|
Topical
| 10
|
mg
|
Four times daily
| 37
|
DRESS syndrome
|
Hypersensitivity
|
Hypersensitivity conditions NEC
|
Allergic conditions
|
Immune system disorders
| 177
| 13
|
Other medically important condition
|
Recovered/Resolved
|
Dose increased
|
Not applicable
|
Not applicable
|
Amoxicillin; Albuterol
|
Alcohol use disorder; Chronic kidney disease
|
Consumer
|
Spontaneous
|
Unlikely
| 16
| 33
| 1
| 0.7
| 12
|
26093CE7ACCAE7D2
|
2023-07-06
|
NLD
| 55
|
adult
|
Male
| 82.5
|
Hepatosan
|
Bipolar disorder
|
Ophthalmic
| 25
|
mg
|
As needed
| 73
|
Auditory hallucinations
|
Suicidal ideation
|
Depressive disorders
|
Mental disorders NEC
|
Psychiatric disorders
| 159
| 16
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
| null |
Rheumatoid arthritis
|
Consumer
|
Literature
|
Probable/Likely
| null | 37
| 1
| null | null |
C0B7FD60ABE1ACFF
|
2021-07-29
|
FIN
| 87
|
elderly
|
Female
| 59.1
|
Infectoban
|
Migraine prophylaxis
|
Topical
| 10
|
mg
|
Four times daily
| 5
|
Right ventricular failure
|
Arrhythmia
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 24
| 3
|
Non-serious
|
Recovered with sequelae
|
Dose not changed
|
Not applicable
|
Not applicable
|
Aspirin
|
Previous stroke; Benign prostatic hyperplasia
|
Pharmacist
|
Spontaneous
|
Possible
| 32
| 13
| null | 1.2
| 11
|
27D3BDF733D6D5B8
|
2025-09-30
|
NZL
| 80
|
elderly
|
Male
| null |
Psychostabil
|
Hypertension
|
Subcutaneous
| 2
|
mg
|
Twice daily
| null |
Cardiac arrest
|
Cardiac failure acute
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 6
| 16
|
Non-serious
|
Recovering/Resolving
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Hydrochlorothiazide
|
Previous myocardial infarction; Diabetes mellitus type 2
|
Physician
|
Spontaneous
|
Possible
| null | 13
| 0.5
| null | 18
|
B00D32B56922FBCF
|
2022-10-09
|
FRA
| 42
|
adult
|
Unknown
| null |
Oncotreat
|
Pain management
|
Intravenous
| 500
|
mg
|
Twice daily
| null |
Contact dermatitis
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 164
| null |
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Simvastatin; Levothyroxine
|
Hypertension
|
Physician
|
Literature
|
Possible
| null | 12
| 0.2
| 1.2
| 14
|
F3B5517E735AFF5E
|
2023-12-05
|
FRA
| 61
|
adult
|
Male
| 79.8
|
Sleepwell
|
Type 2 diabetes
|
Oral
| 20
|
mg
|
Twice daily
| 337
|
Decreased WBC
|
Anemia
|
Neutropenias
|
White blood cell disorders
|
Blood and lymphatic system disorders
| 99
| 12
|
Non-serious
|
Recovered/Resolved
|
Drug withdrawn
|
Positive
|
Not applicable
|
Azithromycin; Simvastatin
|
Previous stroke; Hepatitis B
|
Pharmacist
|
Spontaneous
|
Possible
| 13
| null | 0.6
| 1.2
| 9
|
7B7475EC570AEF49
|
2024-02-07
|
RUS
| 81
|
elderly
|
Female
| 57.9
|
Hepatosan
|
Hyperlipidemia
|
Transdermal
| 5
|
mg
| null | 722
|
Cerebrovascular accident
|
Hypertension
|
Hypertension
|
Vascular hypertensive disorders
|
Vascular disorders
| 24
| null |
Non-serious
|
Recovered/Resolved
|
Unknown
|
Not applicable
|
Not applicable
|
Clopidogrel; Azithromycin
|
Coronary artery disease; Rheumatoid arthritis
|
Pharmacist
|
Spontaneous
|
Possible
| null | 36
| null | null | 20
|
AB29505FFE1ED1A8
|
2025-07-30
|
MEX
| 49
|
adult
|
Female
| 88.5
|
Pulmofix
|
Hyperlipidemia
|
Rectal
| 10
|
mg
|
As needed
| 459
|
Mixed hepatic injury
|
Hepatitis acute
|
Liver failures and associated disorders
|
Liver disorders
|
Hepatobiliary disorders
| 145
| null |
Disability
|
Not recovered/Not resolved
|
Drug withdrawn
|
Positive
|
Positive
|
Acetaminophen; Ibuprofen
|
Chronic pain
|
Consumer
|
Spontaneous
|
Certain
| 787
| 439
| null | 0.9
| 16
|
DF79D294304A19A0
|
2025-06-16
|
SWE
| 1
|
neonate
|
Female
| 43.2
|
Anticoag-XR
|
Osteoarthritis
|
Intravenous
| 50
|
mg
|
Twice daily
| null |
Oliguria
|
Acute kidney injury
|
Acute renal failures
|
Renal failures and impairments
|
Renal and urinary disorders
| 135
| 14
|
Life-threatening
|
Recovered/Resolved
|
Unknown
|
Not applicable
|
Not applicable
|
Losartan
|
Asthma; Peripheral vascular disease; Depression
|
Physician
|
Clinical trial
|
Unlikely
| 12
| 36
| 0.2
| 4.5
| null |
9E688451BE8B18B8
|
2023-07-04
|
CHE
| 49
|
adult
|
Male
| 98.4
|
Neurobalance
|
Pain management
|
Topical
| 25
|
mg
|
As needed
| 330
|
Arthritis pain
|
Muscle weakness
|
Myopathies
|
Muscle disorders
|
Musculoskeletal and connective tissue disorders
| 138
| 78
|
Non-serious
|
Not recovered/Not resolved
|
Drug withdrawn
|
Unknown
|
Not applicable
|
Losartan; Omeprazole; Prednisone
|
Hepatitis B; Benign prostatic hyperplasia
|
Consumer
|
Spontaneous
|
Unlikely
| 45
| 32
| null | 0.7
| 17
|
13D042D55DAC3022
|
2022-02-06
|
NLD
| 36
|
adult
|
Unknown
| 103.3
|
Lipidlow
|
Seizure disorder
|
Topical
| 25
|
mg
|
Three times daily
| 433
|
Acute heart failure
|
Cardiac failure acute
|
Heart failures NEC
|
Heart failures
|
Cardiac disorders
| 1
| 49
|
Other medically important condition
|
Recovered/Resolved
|
Drug withdrawn
|
Not applicable
|
Not applicable
|
Amoxicillin; Furosemide; Omeprazole
|
Peripheral vascular disease; Occupational chemical exposure; Hypothyroidism
|
Pharmacist
|
Clinical trial
|
Possible
| 12
| null | 1.1
| 1.2
| 15
|
8E265E7053ED510E
|
2025-08-30
|
USA
| 44
|
adult
|
Male
| 117.6
|
Eyeprotect
|
Asthma
|
Subcutaneous
| 25
|
mg
|
Four times daily
| 231
|
New malignancy
|
Carcinoma
|
Leukaemias NEC
|
Malignant neoplasms
|
Neoplasms benign, malignant and unspecified
| 125
| 76
|
Non-serious
|
Recovering/Resolving
|
Dose not changed
|
Not applicable
|
Not applicable
|
Insulin; Losartan; Amlodipine
|
Hyperlipidemia; Chronic kidney disease; Benign prostatic hyperplasia; Chronic pain
|
Physician
|
Spontaneous
|
Unlikely
| 37
| null | 0.7
| 0.8
| null |
59701888752D54BD
|
2022-10-01
|
IND
| 56
|
adult
|
Unknown
| null |
Anticoag-XR
|
GERD
|
Intramuscular
| 25
|
mg
|
Once daily
| 518
|
Skin rash
|
Toxic epidermal necrolysis
|
Rashes, eruptions and exanthems NEC
|
Epidermal and dermal conditions
|
Skin and subcutaneous tissue disorders
| 18
| 52
|
Life-threatening
|
Recovered with sequelae
|
Dose not changed
|
Not applicable
|
Not applicable
|
Insulin
|
Occupational radiation exposure
|
Consumer
|
Spontaneous
|
Possible
| 45
| null | 0.8
| 1.2
| null |
Synthetic FAERS-Style Pharmacovigilance Dataset (1M Records)
Dataset Description
This is a fully synthetic dataset designed for pharmacovigilance signal detection and ML model training. Contains 1,000,000 synthetic Individual Case Safety Reports (ICSRs).
Features
- 100% Synthetic: No real patient data - GDPR/HIPAA compliant
- 1M Records: Large-scale dataset for ML training
- 35 Features: Causality, temporal, lab values, demographics
- 700+ Drug-Event Signals: Realistic signal patterns
Files
synthetic_faers_1m_pv_signal_ml.csv- PV Signal ML compatible (recommended)synthetic_faers_1m_v2.csv- Original column names
Quick Start
from datasets import load_dataset
Load the dataset dataset = load_dataset("koreo/synthetic-faers-1m-v2", data_files="synthetic_faers_1m_pv_signal_ml.csv", split="train")
Convert to pandas df = dataset.to_pandas() print(f"Loaded {len(df):,} records")
Schema
Drug Information:
- drug_name, dose, route, therapy_duration
Event Information (MedDRA):
- llt, pt, hlt, hlgt, soc
Causality Features:
- dechallenge, rechallenge, causality, action_drug
Temporal:
- ttp_days (time to onset), event_duration
Demographics:
- age, sex, weight, country
Lab Values:
- alt, ast, bilirubin, creatinine, bun
Other:
- concomitant_drugs, medical_history, serious, outcome
Privacy
✅ GDPR Compliant
✅ HIPAA Compliant
✅ 100% Synthetic
✅ No PII/PHI
License
CC0-1.0 (Public Domain)
- Downloads last month
- 12